Copyright Reports & Markets. All rights reserved.

Global Dermal filler and Botolinum Toxin Market Professional Survey Report 2019

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Dermal filler and Botolinum Toxin Industry
  • 1.7 COVID-19 Impact: Dermal filler and Botolinum Toxin Market Trends

    • 2 Global Dermal filler and Botolinum Toxin Quarterly Market Size Analysis

    • 2.1 Dermal filler and Botolinum Toxin Business Impact Assessment - COVID-19
      • 2.1.1 Global Dermal filler and Botolinum Toxin Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Dermal filler and Botolinum Toxin Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Dermal filler and Botolinum Toxin Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Dermal filler and Botolinum Toxin Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Dermal filler and Botolinum Toxin Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Dermal filler and Botolinum Toxin Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Dermal filler and Botolinum Toxin Market
    • 3.5 Key Manufacturers Dermal filler and Botolinum Toxin Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Dermal filler and Botolinum Toxin Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Aesthetic Volume Restoration
      • 1.4.2 Wrinkle Reduction
    • 4.2 By Type, Global Dermal filler and Botolinum Toxin Market Size, 2019-2021
      • 4.2.1 By Type, Global Dermal filler and Botolinum Toxin Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Dermal filler and Botolinum Toxin Price, 2020-2021

    5 Impact of Covid-19 on Dermal filler and Botolinum Toxin Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hyaluronic Acid Based Fillers
      • 5.5.2 Non-Hyaluronic Acid Based Fillers
      • 5.5.3 Botulinum Toxin
    • 5.2 By Application, Global Dermal filler and Botolinum Toxin Market Size, 2019-2021
      • 5.2.1 By Application, Global Dermal filler and Botolinum Toxin Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Dermal filler and Botolinum Toxin Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Allergan
      • 7.1.1 Allergan Business Overview
      • 7.1.2 Allergan Dermal filler and Botolinum Toxin Quarterly Production and Revenue, 2020
      • 7.1.3 Allergan Dermal filler and Botolinum Toxin Product Introduction
      • 7.1.4 Allergan Response to COVID-19 and Related Developments
    • 7.2 Galderma
      • 7.2.1 Galderma Business Overview
      • 7.2.2 Galderma Dermal filler and Botolinum Toxin Quarterly Production and Revenue, 2020
      • 7.2.3 Galderma Dermal filler and Botolinum Toxin Product Introduction
      • 7.2.4 Galderma Response to COVID-19 and Related Developments
    • 7.3 Merz Pharma GmbH & Co. KGaA
      • 7.3.1 Merz Pharma GmbH & Co. KGaA Business Overview
      • 7.3.2 Merz Pharma GmbH & Co. KGaA Dermal filler and Botolinum Toxin Quarterly Production and Revenue, 2020
      • 7.3.3 Merz Pharma GmbH & Co. KGaA Dermal filler and Botolinum Toxin Product Introduction
      • 7.3.4 Merz Pharma GmbH & Co. KGaA Response to COVID-19 and Related Developments
    • 7.4 Anika Therapeutics
      • 7.4.1 Anika Therapeutics Business Overview
      • 7.4.2 Anika Therapeutics Dermal filler and Botolinum Toxin Quarterly Production and Revenue, 2020
      • 7.4.3 Anika Therapeutics Dermal filler and Botolinum Toxin Product Introduction
      • 7.4.4 Anika Therapeutics Response to COVID-19 and Related Developments
    • 7.5 Suneva Medical
      • 7.5.1 Suneva Medical Business Overview
      • 7.5.2 Suneva Medical Dermal filler and Botolinum Toxin Quarterly Production and Revenue, 2020
      • 7.5.3 Suneva Medical Dermal filler and Botolinum Toxin Product Introduction
      • 7.5.4 Suneva Medical Response to COVID-19 and Related Developments
    • 7.6 Contura
      • 7.6.1 Contura Business Overview
      • 7.6.2 Contura Dermal filler and Botolinum Toxin Quarterly Production and Revenue, 2020
      • 7.6.3 Contura Dermal filler and Botolinum Toxin Product Introduction
      • 7.6.4 Contura Response to COVID-19 and Related Developments
    • 7.7 HUGEL
      • 7.7.1 HUGEL Business Overview
      • 7.7.2 HUGEL Dermal filler and Botolinum Toxin Quarterly Production and Revenue, 2020
      • 7.7.3 HUGEL Dermal filler and Botolinum Toxin Product Introduction
      • 7.7.4 HUGEL Response to COVID-19 and Related Developments
    • 7.8 Grex Pharma
      • 7.8.1 Grex Pharma Business Overview
      • 7.8.2 Grex Pharma Dermal filler and Botolinum Toxin Quarterly Production and Revenue, 2020
      • 7.8.3 Grex Pharma Dermal filler and Botolinum Toxin Product Introduction
      • 7.8.4 Grex Pharma Response to COVID-19 and Related Developments
    • 7.9 Daewoong Pharmaceuticals
      • 7.9.1 Daewoong Pharmaceuticals Business Overview
      • 7.9.2 Daewoong Pharmaceuticals Dermal filler and Botolinum Toxin Quarterly Production and Revenue, 2020
      • 7.9.3 Daewoong Pharmaceuticals Dermal filler and Botolinum Toxin Product Introduction
      • 7.9.4 Daewoong Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.10 Medy-Tox
      • 7.10.1 Medy-Tox Business Overview
      • 7.10.2 Medy-Tox Dermal filler and Botolinum Toxin Quarterly Production and Revenue, 2020
      • 7.10.3 Medy-Tox Dermal filler and Botolinum Toxin Product Introduction
      • 7.10.4 Medy-Tox Response to COVID-19 and Related Developments
    • 7.11 TEOXANE Laboratories
      • 7.11.1 TEOXANE Laboratories Business Overview
      • 7.11.2 TEOXANE Laboratories Dermal filler and Botolinum Toxin Quarterly Production and Revenue, 2020
      • 7.11.3 TEOXANE Laboratories Dermal filler and Botolinum Toxin Product Introduction
      • 7.11.4 TEOXANE Laboratories Response to COVID-19 and Related Developments
    • 7.12 SciVision Biotech
      • 7.12.1 SciVision Biotech Business Overview
      • 7.12.2 SciVision Biotech Dermal filler and Botolinum Toxin Quarterly Production and Revenue, 2020
      • 7.12.3 SciVision Biotech Dermal filler and Botolinum Toxin Product Introduction
      • 7.12.4 SciVision Biotech Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Dermal filler and Botolinum Toxin Supply Chain Analysis
      • 8.1.1 Dermal filler and Botolinum Toxin Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Dermal filler and Botolinum Toxin Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Dermal filler and Botolinum Toxin Distribution Channels
      • 8.2.2 Covid-19 Impact on Dermal filler and Botolinum Toxin Distribution Channels
      • 8.2.3 Dermal filler and Botolinum Toxin Distributors
    • 8.3 Dermal filler and Botolinum Toxin Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Dermal filler and Botolinum Toxin, including the following market information:
      Global Dermal filler and Botolinum Toxin Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Dermal filler and Botolinum Toxin Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Dermal filler and Botolinum Toxin Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Dermal filler and Botolinum Toxin Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

      Key market players
      Major competitors identified in this market include Allergan, Galderma, Merz Pharma GmbH & Co. KGaA, Anika Therapeutics, Suneva Medical, Contura, HUGEL, Grex Pharma, Daewoong Pharmaceuticals, Medy-Tox, TEOXANE Laboratories, SciVision Biotech, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Aesthetic Volume Restoration
      Wrinkle Reduction

      Based on the Application:
      Hyaluronic Acid Based Fillers
      Non-Hyaluronic Acid Based Fillers
      Botulinum Toxin

      Buy now